17 results
SC14D9C
EX-2.1
PNT
POINT Biopharma Global Inc.
3 Oct 23
Written communication relating to third party tender offer
7:37am
) or, to the Company’s knowledge, has been adulterated or misbranded. No proceedings (whether complete or pending) seeking the recall, withdrawal
8-K
EX-2.1
PNT
POINT Biopharma Global Inc.
3 Oct 23
Tender and Support Agreement
7:35am
) or, to the Company’s knowledge, has been adulterated or misbranded. No proceedings (whether complete or pending) seeking the recall, withdrawal
ARS
2022 FY
PNT
POINT Biopharma Global Inc.
1 May 23
Annual report to shareholders
1:52pm
or holder of an approved NDA, including recall. TABLE OF CONTENTS 32
The FDA may withdraw approval if compliance with regulatory requirements and standards … with authorized trading partners. In the event of a recall or an inquiry regarding a potentially illegitimate product, manufacturers must be able to provide
424B3
PNT
POINT Biopharma Global Inc.
31 Mar 22
Prospectus supplement
11:42am
manufacture or distribution;
POINT, or any future collaborators, may be required to recall the product, change the way such product is administered … recall.
The FDA may withdraw approval if compliance with regulatory requirements and standards is not maintained or if problems occur after
POS AM
PNT
POINT Biopharma Global Inc.
25 Mar 22
Prospectus update (post-effective amendment)
8:41am
to recall the product, change the way such product is administered to patients or conduct additional clinical trials;
additional restrictions may … in restrictions on a product, manufacturer or holder of an approved NDA, including recall.
The FDA may withdraw approval if compliance with regulatory
424B3
wzqcinetjtp mim0d4ga
5 Aug 21
Prospectus supplement
4:26pm
424B3
nlm3lj752up sgq
9 Jun 21
Prospectus supplement
4:42pm
S-4/A
EX-10.16
c6j6 fl3s
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4/A
EX-10.19
06aq1bfrbyf ryjup20
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4/A
oci9se9 y76t
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4
EX-10.16
trb7ctxms qx7x1juhh
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
S-4
zranaxjol0ekr s9r
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
8-K/A
EX-2.1
40lj aknhiq12
18 Mar 21
Financial Statements and Exhibits
9:08am
- Prev
- 1
- Next